What is Burkholderia Cepacia Infection Market?
The burkholderia cepacia infection is triggered by burkholderia cepacia. Burkholderia cepacia (also known as Pseudomonas cepacia) is a bacterium species that is generally found in natural surroundings such as soil, water, rhizosphere and agricultural products. In 1949 Walter H. Burkholder discovered identified Burkholderia cepacia bacteria as the source of onion skin rot (cepacia is Latin for “like onion”). By the 1990s, taxonomists found that Burkholderia cepacia have different characteristics and sufficiently different from Pseudomonas aeruginosa and since then this species of the new genus Burkholderia appeared.. It is an opportunistic pathogen that causes disease primarily among immunocompromised populations. As per the sources, it is estimated that by 2025 over 100 million people would suffer from asthma worldwide. The signs and symptoms of burkholderia cepacia infection vary from person to person and may cause the risk of chronic lung diseases. The growing cases of COPD and asthma will contribute to the global burkholderia cepacia infection market size in the forecast period.
The market study is being classified, by Application (Kids and Adults) and major geographies with country level break-up.
Novabiotics Ltd (United Kingdom), Aridis Pharmaceuticals LLC (United States), NanoBio Corporation (United States), iQur Ltd. (United Kingdom), Sun Pharmaceutical Industries Limited (India), Charles River Laboratories (United States), bioMerieux, Inc. (France) and Thermo Scientific (United States) are some of the key players profiled in the study.
The global burkholderia cepacia infection market consists of few established players accounting for the major market shares. These key players are competing through innovations in drug development to gain popularity in the market. The entry of private-labels in the market is expected to increase the competition among the providers. Research Analyst at AMA predicts that United States and European Players will contribute to the maximum growth of Global Burkholderia Cepacia Infection market throughout the predicted period.
Analyst at AMA have segmented the market study of Global Burkholderia Cepacia Infection market by Type, Application and Region.
On the basis of geography, the market of Burkholderia Cepacia Infection has been segmented into South America (Brazil, Argentina, Rest of South America), Asia Pacific (China, Japan, India, South Korea, Taiwan, Australia, Rest of Asia-Pacific), Europe (Germany, France, Italy, United Kingdom, Netherlands, Rest of Europe), MEA (Middle East, Africa), North America (United States, Canada, Mexico). Additionally, the rising demand from SMEs and various industry verticals gives enough cushion to market growth.
- Increasing Awareness Among People About Burkholderia Cepacia Infection
- Growing Occurrences Of Chronic Lung Diseases
- Increasing Healthcare Spending and Demand for Drug Therapy
- Lack of Awareness in Rural Areas
- Increasing Number Of Investments By Regulatory Authorities
- Continuous Research And Development Activities
- Stringent Government Rules and Regulation
In August 2019, VenatoRx Pharmaceuticals received approximately USD 20.7 million grant for two years from Biomedical Advanced Research and Development Authority (BARDA) to test the efficacy of VNRX-5133 compound in treating pathogens, specifically, melioidosis-causing bacterium Burkholderia pseudomallei.
Key Target AudienceNew Entrants/Investors, Analysts and Strategic Business Planners, Burkholderia Cepacia Infection Manufacturer, Venture Capitalists and Private Equity Firms, Government Regulatory and Research Organizations and End Use Industry
Customization in the Report Available:The Study can be customized to meet your requirements. Please connect with our representative, who will ensure you get a report that suits your needs.
Data related to EXIM [Export- Import], production & consumption by country or regional level break-up can be provided based on client request**
** Confirmation on availability of data would be informed prior purchase